colonoscopy,sedation. Failed moderate sedation during procedure
Conditions
Interventions
Intervention 1: The intervention group will use propofol with a dose of 0.5 mg per kg and dexmedetomidine with a dose of 1 mg per kg and at a rate of 0.5 mg per kg per hour manufactured by Daro Farah
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: The absence of cardiovascular diseases The absence of kidney or liver failure diseases absence of drug addiction absence of contraindications to the use of dexmedetomidine, propofol people which are classified in class 1 and 2 of the American Society of Anesthesiology (II, I class ASA) are selected.
Exclusion criteria
Exclusion criteria: Unwillingness of the patient to participate in the study intestinal perforation during procedure bleeding of the esophagus or stomach or intestine during the procedure changing the type of procedure during colonoscopy or requiring surgery during the procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total amount of Propofol consumed. Timepoint: From start to end of colonoscopy. Method of measurement: Dose of drug.;Level of sedation. Timepoint: From start to end of colonoscopy. Method of measurement: Ramsay Sedation Scale.;Amount of pain. Timepoint: From start to one hour after colonoscopy. Method of measurement: Visual Analogue Scale.;Amount of Nausea and Vomiting. Timepoint: From start to end of colonoscopy. Method of measurement: Visual Analogue Scale.;Time of recovery. Timepoint: From start to end of colonoscopy. Method of measurement: From end of colonoscopy to full consciousness.;Hemodynamic instability. Timepoint: From start to end of colonoscopy. Method of measurement: Amount of Heart rate, mean arterial pressure and blood oxygen saturation changes. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Moftakhar
Ahvaz University of Medical Sciences
Outcome results
None listed